REBECCA DIDI: Open Payments
NPI 1306862958 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 103 payments from 18 companies in 2025. Trend: 2023 $1,248 · 2024 $1,380 · 2025 $1,837
Food & beverage: $1,769Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $242 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $202 |
| Amgen Inc. | 16 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $146 |
| GlaxoSmithKline, LLC. | 19 | $141 |
| Otsuka America Pharmaceutical, Inc. | 8 | $140 |
| Astellas Pharma US Inc | 3 | $114 |
| Exact Sciences Corporation | 6 | $112 |
| Radius Health, Inc. | 4 | $99 |
| Lilly USA, LLC | 4 | $96 |
Products named: BREZTRI, Kerendia, CAPLYTA, REXULTI, EVENITY, Cologuard Collection Kit, TRELEGY ELLIPTA, OTEZLA.
Industry payments across FL — which companies pay providers there.
